China-based biotech company WuXi AppTec and its affiliate said they don’t pose any security risk to the U.S. or other nations after the U.S. House of Representatives passed a draft Biosecure Act.
The latest restructuring measures will lead to pre-tax charges of $140 million to $160 million for the fiscal years ending in March 2025 and 2026, the sportswear maker said.
